Xenon Pharmaceuticals Inc — Quarterly Financial Data (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Notícias

Alibaba Earnings, Jobs Data

Ações da Xenon Pharmaceuticals atingem máxima de 52 semanas a US$ 46,68

Xenon Pharmaceuticals stock hits 52-week high at $46.68

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Xenon earnings loom as investors brace for Phase 3 catalyst

Wolfe Research inicia cobertura de ações da Xenon Pharmaceuticals com classificação acima da média

Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

Stifel eleva preço-alvo das ações da Xenon Pharmaceuticals para US$ 66 devido ao potencial do XEN1101

Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential

Biohaven stock rating upgraded by RBC Capital on promising CNS data

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12